Search Results
Found 1 results
510(k) Data Aggregation
(308 days)
MedWand
The MedWand™ Device, in combination with the MedWand™ Software Application installed on an attached mobile device or computing system, is an intermittent vital sign measuring and examination system intended to collect, record, and display the following information:
- · Oxygen saturation (SpO2),
- · Pulse rate (PR),
- · Infrared body temperature (TEMP)
- · Amplified auscultation sounds filtered for heart, lungs, and abdomen (STETH)
- · Photographs of areas needing assessment (CAMERA)
The device is intended for use by adult lay users independently or guided by a health care professional (HCP) in home and non-acute clinical environments.
The MedWand™ Device is intended for use by trained adults only who can use smart phones, tablets, or computers proficiently.
Collected information is not intended for self-diagnosis. Interpretation and assessment of results should be performed by an HCP. Collected information can be provided to a HCP when used as a standalone device.
Additionally, the MedWand™ Device can integrate with external data communications systems (not part of the MedWand™ Device) through a programming interface. This integration will facilitate interactions between the lay user and HCP for telemedicine. The device is intended for spot-checking and does not have continuous monitoring capability or alarm features.
The MedWand™ Device is a handheld telemedicine device that allows measurement of SpO2. pulse rate, and stethoscope along with a camera. The device is intended to be used by lay people or clinical personnel. The patient applies their finger to the sensor on the top of the device designed for measuring SpO2 and pulse rate. The thermometer is a non-contact IR thermometer that is pointed to the patient's forehead. The camera can be pointed to the particular body part at the (remote) Health Care Professional's (HCP) direction. The stethoscope is contacted directly to the patient's chest or abdomen to provide auscultation sounds to the (remote) HCP.
The MedWand™ Device works as part of the MedWand™ Ecosystem. The MedWand™ Ecosystem consists for following elements:
-
- MedWand™ Device including its embedded firmware This device is provided to the patient or other user who is physically present with the patient.
-
- USB-C cable provided with the device. This cable physically connects the MedWand™ Device to the mobile device or computing platform to provide power, communications, and control for the MedWand™ Device
-
- Client App Software Proprietary software that is provided to the patient or user to run on their mobile device or computing platform (MCP). This software is available for both Windows-based and Android-based devices. This software supports the local operation of the MedWand™ Device and the use of the device in the context of a telemedicine system. This software contains the user interface to the MedWand™ Device. This software provides the user with the concept of a session in which the user activates one or more sensors, collects readings for temperature and pulse oximeter, photos from the camera, and recordings from the stethoscope.
-
- Device Communications Module (DCM) The DCM runs on the MCP incorporated as a library in the Client App. The DCM manages the serial communications between the MedWand™ Device and MCP. The DCM is also known as the Software Developer's Kit (SDK), as it provides a controlled programming interface to enable integration with thirdparty telemedicine systems.
-
- A mobile device (e.g., laptop, tablet or smartphone) or computing platform (laptop or computer) (collectively Mobile Computing Platform (MCP)) – The MCP is supplied by the patient or user, not by MedWand. The Client App proprietary software runs the MCP. The MCP is not part of the medical device.
-
- A clinician receiving platform located in a clinical environment (e.g., a PC at the clinic, not supplied by MedWand and not part of the medical device). As described in the cited FDA guidance, this platform and any clinician interface are not part of the medical device.
-
- Commercial Telemedicine systems provides real-time voice and video communications between the HCP and the MedWand™ Device user (as patient) in a virtual live visit. These external software systems would be classified as Medical Device Data Systems, which FDA no longer considers medical devices.
Here's a breakdown of the acceptance criteria and study information for the MedWand™ Device based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
Note: The document provides performance details for individual functions (SpO2, Pulse Rate, Temperature) but explicitly states that the MedWand™ Device met "the more stringent required acceptance criteria from the FDA guidance for reflectance pulse oximeters" and that thermometer results are "similar to other published temperature data for IR thermometers." The exact numerical acceptance criteria from the FDA guidance or standards are not fully specified for all metrics in this document, but the device's performance against them is confirmed.
Function/Metric | Acceptance Criteria (where explicitly stated or implied) | Reported Device Performance (MedWand™ Device) |
---|---|---|
SpO2 Accuracy (ARMS) | ISO 80601-2-61:2017 & FDA guidance for reflectance pulse oximeters (more stringent) | 70-80%: 3.00% |
80-90%: 1.62% | ||
90-100%: 1.37% | ||
70-100%: 2.05% | ||
SpO2 Displayed Range | 70%~100% (Implied by predicate comparison) | 70%~100% |
Pulse Rate Measurement Range | 30 to 150 bpm (Implied by predicate comparison) | 25 to 200 bpm |
Pulse Rate Accuracy | ± 2 bpm or ± 2% (whichever is greater) | ± 2 bpm or ± 2% (whichever is greater) |
Temperature Measurement Range (body) | 93.2°F~109.4°F (34.0°C ~43.0°C) (Implied by predicate comparison) | 93°F~107.6°F (33.9°C ~42.0°C) |
Temperature Measurement Accuracy | ± 0.5°F (± 0.3°C) | ± 0.5°F (± 0.3°C) |
Thermometer Febrile Subjects | 30-50% febrile (from associated particular standard) | 37% (59/158 subjects) |
Electrical Safety & EMC | IEC 60601 3.1 edition standards, including ANSI/AAMI/ES60601 with U.S. deviations, ANSI/AAMI/IEC 60601-1-11:2015, and IEC 60601-1-2:2014 | Complies with all requirements |
Biocompatibility | ISO 10993-1, ISO 10993-5, ISO 10993-10 | Biocompatible |
Software Level of Concern (LOC) | Moderate | Moderate LOC |
2. Sample Sizes and Data Provenance
For SpO2 Accuracy Study (Controlled Hypoxia):
- Sample Size: 14 healthy volunteer subjects
- Test Set Description: Ages 21-40; 6/14 male (42%); range of ethnicities, including at least 28% (4/14) with dark skin tones.
- Data Provenance: Not explicitly stated, but the nature of a "controlled hypoxia" study strongly suggests prospective clinical data collected specifically for this validation in a controlled environment. Country of origin not specified.
For Thermometer & Additional SpO2/PR Clinical Agreement Study:
- Sample Size: 158 subjects
- Test Set Description: Patients from an outpatient health clinic; ages 18-81 (median 35, mean 37); 64/158 male (41%); skin tones 1-6 (dark) with median 2; 59/158 (37%) presented febrile symptoms.
- Data Provenance: Not explicitly stated, but implies prospective clinical data collected from an outpatient health clinic. Country of origin not specified.
3. Number of Experts and Qualifications for Ground Truth
The document does not explicitly state the number or specific qualifications of experts used to establish ground truth for the test sets. However, it references established methods:
- For SpO2: Arterial blood samples were measured for SaO2 on a cooximeter, which is a highly accurate reference method. This implicitly relies on the calibration and proper operation of the cooximeter.
- For Temperature: A "well-established reference clinical thermometer" was used, specifically mentioning the Exergen TAT thermometer (K011291) as a reference predicate in the comparison table, which uses rectal as the reference body site.
4. Adjudication Method for the Test Set
The document does not mention any adjudication method (e.g., 2+1, 3+1) for the test sets. The ground truth was established using objective, established reference methods (cooximetry for SpO2, reference clinical thermometer for temperature).
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No MRMC comparative effectiveness study is mentioned. The studies described are device performance studies against reference standards.
6. Standalone Performance Study
Yes, the clinical studies evaluate the performance of the MedWand™ Device in a standalone manner against established reference methods. For example, the SpO2 data from the MedWand™ pulse oximeter was compared directly to SaO2 results from a cooximeter. Similarly, MedWand™ temperature readings were compared to a reference clinical thermometer.
7. Type of Ground Truth Used
- For SpO2: Physiological ground truth established by arterial blood gas analysis (SaO2 measured by cooximeter).
- For Temperature: Physiological ground truth established by a reference clinical thermometer (Exergen TAT thermometer, K011291, with rectal as the reference body site).
8. Sample Size for the Training Set
The document does not specify a separate "training set" sample size for the device's algorithms. The clinical studies described are explicitly for validation of the finished device.
9. How Ground Truth for Training Set Was Established
Since a separate "training set" with ground truth establishment is not described in the context of machine learning (which might use such a set for model development), this information is not provided. The performance data presented is from validation studies comparing the device to accepted medical reference standards.
Ask a specific question about this device
Page 1 of 1